Neoadjuvant semaglutide showed no benefit in weight loss, diabetes remission or safety in a cohort of patients who underwent metabolic and bariatric surgery, according to study results published ...

Semaglutide vs. Liraglutide Semaglutidetends to be more effective than liraglutide, providing a 15.8% average weight loss, compared to 6.4%. It also has a much longer half-life, meaning that it ...

Semaglutide was initiated at a dose of 0.25 mg once weekly, and the dose was increased every 4 weeks in accordance with recommended dosing (from 0.25 mg to 0.5 mg, 1.0 mg, 1.7 mg, and 2.4 mg ...

You can take semaglutide for weight loss indefinitely. There’s no set cut-off time, as the drug was originally designed as a diabetes medication and intended for long-term use.

The U.S. Food and Drug Administration has issued a new warning about a popular medication used for weight loss. The FDA says it has received reports of people overdosing on compounded semaglutide ...

Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. N Engl J Med. 2023;389 (24):2221-2232. doi: 10.1056/NEJMoa2307563.

When it comes to semaglutide, withdrawal symptoms can involve changes related to weight, appetite, blood sugar levels, and cardiovascular health. When you regularly take a medication that alters ...

Semaglutide is a perfect GLP-1 to study first in type 1 diabetes because it has been approved for quite some time and has lots of important indications in type 2 diabetes that might pertain to ...

Furthermore, those in the semaglutide group had a significantly lower proportionate increase in urinary albumin -to- creatinine ratio (UACR) compared with placebo (–10.7%; P < .001) at the pre ...

Hathaway JT, Shah MP, Hathaway DB, et al. Risk of nonarteritic anterior ischemic optic neuropathy in patients prescribed semaglutide. JAMA Ophthalmol. 2024;142 (8):732-739. doi:10.1001 ...